We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+11.07%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$48.8B
AUM Growth
+$7.31B
(+18%)
Cap. Flow
+$2.97B
Cap. Flow
% of AUM
6.1%
Top 10 Holdings %
Top 10 Hldgs %
18.45%
Holding
760
New
71
Increased
309
Reduced
252
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$305M |
| 2 |
CVS Health
CVS
|
+$190M |
| 3 |
Novartis
NVS
|
+$175M |
| 4 |
Broadcom
AVGO
|
+$154M |
| 5 |
Western Digital
WDC
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halliburton
HAL
|
+$260M |
| 2 |
UnitedHealth
UNH
|
+$217M |
| 3 |
United Parcel Service
UPS
|
+$140M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$137M |
| 5 |
McKesson
MCK
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.38% |
| 2 | Healthcare | 15.25% |
| 3 | Technology | 13.09% |
| 4 | Industrials | 10.62% |
| 5 | Energy | 10.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Fluor
FLR
$7.29B
| $104M | 0.21% |
1,298,058
-395,409
| -23% | -$30.2M |
|
|
VIAB
127
DELISTED
Viacom Inc. Class B
VIAB
| $103M | 0.21% |
1,178,361
-460,005
| -28% | -$38M |
|
128
Constellation Brands
STZ
$22.2B
| $102M | 0.21% |
1,442,360
+269,485
| +23% | +$18M |
|
129
PepsiCo
PEP
$186B
| $100M | 0.21% |
1,211,084
-73,520
| -6% | -$6.11M |
|
130
American Homes 4 Rent
AMH
$12B
| $99.7M | 0.2% |
6,152,751
+632,039
| +11% | +$10.2M |
|
|
MRC
131
DELISTED
MRC Global
MRC
| $98M | 0.2% |
3,036,585
+583,413
| +24% | +$17.6M |
|
132
Illinois Tool Works
ITW
$81.4B
| $96.6M | 0.2% |
1,149,401
-70,197
| -6% | -$5.54M |
|
133
O-I Glass
OI
$1.39B
| $96.4M | 0.2% |
2,694,419
+219,638
| +9% | +$7.08M |
|
134
EQT Corp
EQT
$33.2B
| $96.3M | 0.2% |
1,969,777
+482,740
| +32% | +$22.8M |
|
135
Electronic Arts
EA
$52.4B
| $95.3M | 0.2% |
4,154,261
-253,279
| -6% | -$6.08M |
|
136
Boston Properties
BXP
$11B
| $93.5M | 0.19% |
931,686
+208,906
| +29% | +$21.6M |
|
|
STI
137
DELISTED
SunTrust Banks, Inc.
STI
| $92.9M | 0.19% |
2,524,927
-2,257,152
| -47% | -$78.7M |
|
138
Cencora
COR
$60.3B
| $92.8M | 0.19% |
1,319,729
-195,425
| -13% | -$13.1M |
|
139
Reinsurance Group of America
RGA
$15.7B
| $92.7M | 0.19% |
1,197,961
-823,988
| -41% | -$60M |
|
|
ROSE
140
DELISTED
ROSETTA RESOURCES INC
ROSE
| $91.9M | 0.19% |
1,912,487
-477,334
| -20% | -$25.7M |
|
141
H.B. Fuller
FUL
$3B
| $90.7M | 0.19% |
1,741,953
+353,087
| +25% | +$17.2M |
|
142
White Mountains Insurance
WTM
$5.47B
| $90.1M | 0.18% |
149,357
-8,607
| -5% | -$5.07M |
|
|
CMA
143
DELISTED
Comerica
CMA
| $83.1M | 0.17% |
1,747,175
+308,625
| +21% | +$13.6M |
|
|
CAM
144
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $82.9M | 0.17% |
1,392,030
+164,368
| +13% | +$9.47M |
|
145
Boston Scientific
BSX
$65.8B
| $82.8M | 0.17% |
6,890,277
+5,965,619
| +645% | +$70.5M |
|
146
Analog Devices
ADI
$181B
| $79M | 0.16% |
1,551,182
-59,486
| -4% | -$2.9M |
|
147
Timken Company
TKR
$9.82B
| $77.2M | 0.16% |
1,957,122
+222,557
| +13% | +$8.69M |
|
|
TSS
148
DELISTED
Total System Services, Inc.
TSS
| $76.6M | 0.16% |
+2,301,731
| New | +$70.7M |
|
149
Curtiss-Wright
CW
$27.7B
| $75.6M | 0.16% |
1,215,642
-484,120
| -28% | -$25.1M |
|
150
Elevance Health
ELV
$81.9B
| $72.9M | 0.15% |
788,828
-49,723
| -6% | -$4.42M |
|
Similar funds
Boston Partners's Q4 2013 Portfolio in Review
As of Q4 2013, Boston Partners held 760 positions worth $48.8B, up 18% from $41.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Boston Partners deployed $2.97B of net new capital in Q4 2013, opening 71 new positions and adding to 309 existing holdings. Its largest new stake was Novartis: 2,524,138 shares worth $182M.
By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Halliburton, an estimated $260M trimmed.
- Boston Partners's largest Q4 2013 buy was Novartis: 2,524,138 shares worth $182M.
- Boston Partners added most to ExxonMobil in Q4 2013, an estimated $305M increase.
- Boston Partners's biggest Q4 2013 reduction was Halliburton, cutting an estimated $260M.
- Boston Partners fully exited NVIDIA in Q4 2013, selling an estimated $131M.
- Boston Partners's ten largest holdings make up 18% of its $48.8B portfolio in Q4 2013.
- Boston Partners opened 71 new positions and closed 53 in Q4 2013.
- Boston Partners's portfolio value rose 18% quarter-over-quarter to $48.8B.
Based on Boston Partners's 13F filing for Q4 2013, filed 6 Feb 2014.